HENT1 AND DCK EXPRESSION PREDICT BENEFIT FROM GEMCITABINE AFTER CURATIVE-INTENT RESECTION IN PANCREATIC ADENOCARCINOMA

被引：0
|
作者：
Marechal, Raphael [1 ]
Bachet, Jean-Baptiste [2 ]
Mackey, John R. [3 ]
Demetter, Pieter [1 ]
Graham, Kathryn [3 ]
Couvelard, Anne [4 ]
Svrcek, Magali [5 ]
Bardier-Dupas, Armelle [2 ]
Hammel, Pascal [4 ]
Sauvanet, Alain [4 ]
Louvet, Christophe [5 ]
Paye, Francois [5 ]
Rougier, Philippe [6 ]
Hannoun, Laurent [2 ]
Andre, Thierry [2 ]
Cass, Carol E. [3 ]
Salmon, Isabelle [1 ]
Emile, Jean-Francois [7 ]
Van Laethem, Jean-Luc [1 ]
机构：
[1] Free Univ Brussels, Hop Erasme, B-1070 Brussels, Belgium
[2] Hop La Pitie Salpetriere, Paris, France
[3] Univ Alberta, Cross Canc Inst, Edmonton, AB T6G 2M7, Canada
[4] Hop Beaujon, Paris, France
[5] Hop St Antoine, F-75571 Paris, France
[6] Hop Europeen Georges Pompidou, Paris, France
[7] Hop Ambroise Pare, Paris, France
来源：
ANNALS OF ONCOLOGY | 2011年 / 22卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：v12 / v12
页数：1
相关论文
共 50 条
  • [31] Recurrence patterns and postrecurrence survival after curative intent resection for pancreatic ductal adenocarcinoma
    Kolbeinsson, Hordur
    Hoppe, Allison
    Bayat, Aqieda
    Kogelschatz, Benjamin
    Mbanugo, Chineze
    Chung, Mathew
    Wolf, Andrea
    Assifi, M. Mura
    Wright, G. Paul
    SURGERY, 2021, 169 (03) : 649 - 654
  • [32] hENT1 gene expression as a predictor of response to gemcitabine and nab-paclitaxel in advanced pancreatic cancer.
    Perera, Sheron
    Jang, Gun Ho
    Zhang, Amy
    Denroche, Robert Edward
    Dodd, Anna
    Ramotar, Stephanie
    Hutchinson, Shawn
    Wang, Yifan
    Tehfe, Mustapha
    Ramjeesingh, Ravi
    Biagi, James Joseph
    Lam, Bernard
    Wilson, Julie
    Notta, Faiyaz
    Fischer, Sandra
    Zogopoulos, George
    Gallinger, Steven
    Grant, Robert C.
    Knox, Jennifer J.
    O'Kane, Grainne M.
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [33] Predictive risk factors for early recurrence in patients with localized pancreatic ductal adenocarcinoma who underwent curative-intent resection after preoperative chemoradiotherapy
    Murata, Yasuhiro
    Ogura, Toru
    Hayasaki, Aoi
    Gyoten, Kazuyuki
    Ito, Takahiro
    Iizawa, Yusuke
    Fujii, Takehiro
    Tanemura, Akihiro
    Kuriyama, Naohisa
    Kishiwada, Masashi
    Sakurai, Hiroyuki
    Mizuno, Shugo
    PLOS ONE, 2022, 17 (04):
  • [34] Prognostic factors of response to adjuvant chemotherapy after curative resection for pancreatic ductal odenocarcinoina: Prognostic impact of CDA, predictive value of DPD for 5FU efficiency, and hENT1 for gemcitabine
    Truchet, Xavier Edouard
    Mallaret, Claire
    Secq, Veronique
    Mancini, Julien
    le Treut, Yves Patrice
    Moutardler, Vincent
    Ouaissl, Mehdl
    Rubis, Marlon
    Nouguered, Emilie
    Delgrande, Jean
    Lavaut, Marie-Noelle
    Ciccolini, Joseph
    Gasmi, Mohamed
    Garcia, Stephane
    Seitz, Jean Francois
    Dahan, Laetitia
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [35] HENT1 tumor levels to predict survival of pancreatic ductal adenocarcinoma patients who received adjuvant gemcitabine and adjuvant 5FU on the ESPAC trials
    Neoptolemos, John P.
    Greenhalf, William
    Ghaneh, Paula
    Palmer, Daniel H.
    Cox, Trevor F.
    Garner, Elizabeth
    Campbell, Fiona
    Mackey, John Robert
    Moore, Malcolm J.
    Valle, Juan W.
    Mcdonald, Alec
    Tebbutt, Niall C.
    Dervenis, Christos
    Glimelius, Bengt
    Charnley, Richard M.
    Lacaine, Francois
    Mayerle, Julia
    Rawcliffe, Charlotte Louise
    Bassi, Claudio
    Buchler, Markus W.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [36] Antitumor effect of gemcitabine-loaded albumin nanoparticle on gemcitabine-resistant pancreatic cancer induced by low hENT1 expression
    Guo, Zhongyi
    Wang, Feng
    Di, Yang
    Yao, Lie
    Yu, Xinzhe
    Fu, Deliang
    Li, Ji
    Jin, Chen
    INTERNATIONAL JOURNAL OF NANOMEDICINE, 2018, 13 : 4869 - 4880
  • [37] DEVELOPMENT OF A PREOPERATIVE PREDICTIVE RISK MODEL OF EARLY RECURRENCE IN RESECTABLE PANCREATIC CANCER AFTER CURATIVE-INTENT RESECTION
    Kim, Kyuwon
    Jo, Seokjung
    Oh, Dongwook
    Song, Tae Jun
    Park, Do Hyun
    Lee, Sung Koo
    Kim, Myung-Hwan
    Song, Ki Byung
    Lee, Jae Hoon
    Hwang, Dae Wook
    Kim, Song Cheol
    Kim, Jin Hee
    Song, Dong Eun
    Lee, Sang Soo
    GASTROENTEROLOGY, 2019, 156 (06) : S321 - S321
  • [38] Investigating the prognostic value of a panel of biomarkers after curative intent resection of pancreatic ductal adenocarcinoma
    Johnson, Benny
    Khalil, Maged F.
    Blansfield, Joseph
    Lin, Fan
    Zhu, Shaobo
    Kirchner, Lester
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (04)
  • [39] Improved Distant Metastasis-Free Survival with Aspirin Use in Patients Undergoing Curative-Intent Resection of Pancreatic Ductal Adenocarcinoma
    Sadek, Kareem
    Alsabbagh, Yaman
    Tice, Mary P.
    Poruk, Katherine E.
    Stauffer, John A.
    JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2024, 239 (05) : S282 - S282
  • [40] Survival benefit of adjuvant chemoradiotherapy for positive or close resection margin after curative resection of pancreatic adenocarcinoma
    Kim, Byoung Hyuck
    Kim, Kyubo
    Jang, Jin-Young
    Kwon, Wooil
    Kim, Hongbeom
    Lee, Kyung-Hun
    Oh, Do-Youn
    Kim, Haeryoung
    Lee, Kyung Bun
    Chie, Eui Kyu
    EJSO, 2020, 46 (11): : 2122 - 2130
12345